Furthermore, studies have shown that the BRCA1 mutation stimulates inflammasome activation and IL-1β secretion via ROS production and cGAS-STING activation, thereby promoting breast cancer metastasis [236]. The gene discussed is IL1B; the disease is breast carcinoma.